Since bone metastasis is one of the most significant pathways in prostate cancer, we hypothesize that TLR‐9 may promote the bone metastasis of prostate cancer via stimulating MDSCs, and it depends on further studies to verify. The gene discussed is TLR9; the disease is prostate cancer.